title: Acute glaucoma and acute corneal oedema in association with tularemia.
abstract: OBJECTIVE
  To describe the clinical course of oculoglandular tularemia with acute glaucoma and corneal oedema.
  
  
  METHODS
  Clinical course, results of laboratory assays and treatment of oculoglandular tularemia in a 58-year-old woman.
  
  
  RESULTS
  The patient had acute glaucoma and corneal oedema in connection with acute tularemia. At the onset of the disease she had a fever (39 degrees C), pains in her muscles and in her right eye. The intraocular pressure, which was 68 mmHg at the beginning was lowered with intravenous and per oral acetatcolamide together with timolol and pilocarpine eyedrops, and because of a narrow anterior chamber, with subsequent laser iridotomies. The tularemia was treated with ciprofloxacin 500 mg twice daily for ten days. Vision was finger counting at the beginning of the disease. The corneal oedema gradually subsided and vision normalized during the two-month follow-up.
  
  
  CONCLUSIONS
  Oculoglandular tularemia was connected with acute glaucoma and corneal oedema.
authors.affiliation: Department of Ophthalmology, Central Hospital of Central Finland.
authors.forename: O
authors.initials: O
authors.lastname: Pärssinen
authors.forename: M
authors.initials: M
authors.lastname: Rummukainen
mesh_terms: D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D015715:Corneal Edema / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007429:Intraocular Pressure; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010277:Parasympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use; D014406:Tularemia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D000890:Anti-Infective Agents; D009883:Ophthalmic Solutions; D010277:Parasympathomimetics; D010862:Pilocarpine; D002939:Ciprofloxacin; D013999:Timolol